32 results
MGH Sedation protocol for mechanically ventilated COVID-19 patients

#Sedation #Analgesia #Protocol #COVID19 #CriticalCare #Treatment #MGH #Management #Coronavirus
MGH Sedation protocol ... mechanically ventilated COVID ... #CriticalCare # ... Treatment #MGH # ... Management #Coronavirus
Mass General Hospital COVID19 Critical Care Treatment Guide

#COVID19 #CriticalCare #Treatment #MGH #Management #Coronavirus #SARSCOV2
General Hospital COVID19 ... Guide #COVID19 ... #CriticalCare # ... Treatment #MGH # ... Management #Coronavirus
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Brief Overview of Treatment ... Agents for COVID ... #COVID19 #Pharmacology ... #Table #Management ... #MGH
Running out of Analgesia and Sedation Medications due to #COVID19?  Anand Swaminathan, MD has put
Medications due to #COVID19 ... Medications #management ... #covid19 #treatment ... #sarscov2 #criticalcare ... sedative #analgesia #pharmacology
COVID-19 review…here is a list of some of the drugs that are currently being used or
most effective treatments ... #CoronaVirus #Treatment ... #Management #Pandemic ... Pharmacotherapy #Pharmacology ... #CriticalCare #
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
virus causing COVID ... InfectiousDiseases #CriticalCare ... EmergencyMedicine #Pharmacology ... #Treatment #Virus ... #Antiviral #Management
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Fluconazole 100 mg ... for effective treatment ... IDSA #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Itraconazolea 200 mg ... itraconazolea 200 mg ... IDSA #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
amphotericin B 2–4 mg ... dose of 20–60 mg ... Leishmaniasis #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
PO (or 400 mg IV ... PO (or 400 mg IV ... IDSA #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology